Cannapharmarx Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 8.86, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Cannapharmarx Inc in Jun 30 2026 quarter, has decreased to 41 days, compared to 48 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 416 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2831 to 2840.

What is Receivable Turnover Ratio?
What is Cannapharmarx Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CPMD Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-94.04 %	-97.36 %	9312.14 %	221.38 %	-39.89 %
Y / Y Revenue Change	19.26 %	87.12 %	-71.25 %	110.34 %	-
Receivable Turnover Ratio (TTM)	8.86	7.57	4.82	7.05	9.69
CPMD's Total Ranking	# 2840	# 2831	# 2820	# 2888	# 1084
Accounts Receivable average collection period days	41	48	76	52	38
Seq. Receivable Change	-1.92 %	-95.78 %	-72.05 %	414.75 %	-56.52 %
Seq. Revenue Change	-55.98 %	352.62 %	-78.89 %	183.5 %	-30.93 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 132
Healthcare Sector	# 417
Overall Market	# 2840

Receivable Turnover Ratio Statistics
High	Average	Low
0.21	0.16	0.12
(Jun 30 2026)		(Jun 30 2025)

CPMD Company Profile • Back to CPMD Efficiency Comparisons • Compare CPMD Receivables Turnover Ratio to its Competitors

Financial Statements
Cannapharmarx Inc 's Accounts Receivable	$ 0 Millions	Visit CPMD's Balance sheet
Cannapharmarx Inc 's Sales TTM	$ 2 Millions	Visit CPMD's Income Statement
Sources of CPMD's Revenues		Visit CPMD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CPMD's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CPMD's Growth Rates	CPMD's Roa	CPMD's Inventory Turnover Ratio	CPMD's Dividend Comparisons
CPMD's Profitability Ratios	CPMD's Roi	CPMD's Asset Turnover Ratio	CPMD's Dividend Growth
CPMD's Valuation Ratios	CPMD's Roe	CPMD's Financial Strength Ratios	CPMD's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Orchestra Biomed Holdings Inc	453.56	$ 31.976 Millions	$ 0.071 Millions
Nakamoto Inc	386.16	$ 28.962 Millions	$ 0.075 Millions
Agape Atp Corporation	190.27	$ 1.152 Millions	$ 0.006 Millions
Hcw Biologics Inc	175.24	$ 6.843 Millions	$ 0.039 Millions
Assembly Biosciences Inc	94.77	$ 74.845 Millions	$ 0.790 Millions
Earth Science Tech Inc	88.94	$ 34.647 Millions	$ 0.390 Millions
Sbc Medical Group Holdings Incorporated	86.85	$ 173.713 Millions	$ 2.000 Millions
Lenz Therapeutics Inc	77.11	$ 21.475 Millions	$ 0.279 Millions
Airsculpt Technologies Inc	64.88	$ 150.724 Millions	$ 2.323 Millions
Arrowhead Pharmaceuticals Inc	60.05	$ 669.495 Millions	$ 11.149 Millions
Fortrea Holdings Inc	56.65	$ 2,676.500 Millions	$ 47.250 Millions
Humacyte Inc	52.69	$ 30.074 Millions	$ 0.571 Millions

Date modified: 2026-08-19T20:05:48+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.